Ashleigh C. McEvoy

Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients

Ashleigh C. McEvoy, Lydia Warburton, Zeyad Al‐Ogaili et al. · BMC Cancer · 2018 · 99 citations · Full text

Medicine, Clinical Sciences, Oncology +17

Longitudinal Monitoring of ctDNA in Patients with Melanoma and Brain Metastases Treated with Immune Checkpoint Inhibitors

Jenny Lee, Alexander M. Menzies, Matteo S. Carlino et al. · Clinical Cancer Research · 2020 · 82 citations · Full text

Medicine, Clinical Sciences, Oncology +17

PD-L1 Expression on Circulating Tumor Cells May Be Predictive of Response to Pembrolizumab in Advanced Melanoma: Results from a Pilot Study

Muhammad A. Khattak, Anna Reid, James Freeman et al. · The Oncologist · 2019 · 78 citations · Full text

Medicine, Clinical Sciences, Oncology +17

Circulating Tumor DNA Predicts Outcome from First-, but not Second-line Treatment and Identifies Melanoma Patients Who May Benefit from Combination Immunotherapy

Gabriela Marsavela, Jenny Lee, Leslie Calapre et al. · Clinical Cancer Research · 2020 · 63 citations · Full text

Medicine, Clinical Sciences, Oncology +17

Sensitive droplet digital PCR method for detection of<i>TERT</i>promoter mutations in cell free DNA from patients with metastatic melanoma

Ashleigh C. McEvoy, Leslie Calapre, Michelle R. Pereira et al. · Oncotarget · 2017 · 56 citations · Full text

Medicine, Molecular Biology, Oncology +17